115 related articles for article (PubMed ID: 15949039)
1. Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease?
Bohr IJ
Lipids Health Dis; 2005 Jun; 4():13. PubMed ID: 15949039
[TBL] [Abstract][Full Text] [Related]
2. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
Carter CJ
Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors for Alzheimer's disease].
Yanagisawa K
Rinsho Shinkeigaku; 2000 Dec; 40(12):1225-7. PubMed ID: 11464462
[TBL] [Abstract][Full Text] [Related]
4. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
Stojakovic T; Scharnagl H; März W
Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
[TBL] [Abstract][Full Text] [Related]
5. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
6. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
7. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol and Alzheimer's disease--is there a relation?
Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
[TBL] [Abstract][Full Text] [Related]
9. APOE and cholesterol homeostasis in Alzheimer's disease.
Leduc V; Jasmin-Bélanger S; Poirier J
Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
[TBL] [Abstract][Full Text] [Related]
10. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
11. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
12. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes.
Rapp A; Gmeiner B; Hüttinger M
Biochimie; 2006 May; 88(5):473-83. PubMed ID: 16376010
[TBL] [Abstract][Full Text] [Related]
13. Neuronal nicotinic acetylcholine receptor-cholesterol crosstalk in Alzheimer's disease.
Barrantes FJ; Borroni V; Vallés S
FEBS Lett; 2010 May; 584(9):1856-63. PubMed ID: 19914249
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
[TBL] [Abstract][Full Text] [Related]
15. Inflammation, genes and zinc in Alzheimer's disease.
Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
[TBL] [Abstract][Full Text] [Related]
16. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
[TBL] [Abstract][Full Text] [Related]
20. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]